La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Pediatrix Medical Group Gestion
Gestion contrôle des critères 3/4
Le PDG Pediatrix Medical Group's est Jim Swift, nommé en Jan2023, a un mandat de 1.58 ans. La rémunération annuelle totale est $ 2.24M, composée du salaire de 29% et des bonus 71%, y compris les actions et options de la société. détient directement 0.21% des actions de la société, d'une valeur de $ 1.89M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2.6 ans et 4.1 ans.
Informations clés
Jim Swift
Directeur général
US$2.2m
Rémunération totale
| Pourcentage du salaire du PDG | 29.0% |
| Durée du mandat du directeur général | 1.6yrs |
| Propriété du PDG | 0.2% |
| Dur ée moyenne d'occupation des postes de direction | 2.6yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 4.1yrs |
Mises à jour récentes de la gestion
Recent updates
Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified
Aug 07
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?
Nov 17These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well
Oct 23Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Oct 08Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$252m |
| Mar 31 2024 | n/a | n/a | -US$71m |
| Dec 31 2023 | US$2m | US$650k | -US$60m |
| Sep 30 2023 | n/a | n/a | US$88m |
| Jun 30 2023 | n/a | n/a | US$95m |
| Mar 31 2023 | n/a | n/a | US$98m |
| Dec 31 2022 | US$1m | US$450k | US$63m |
Rémunération vs marché: La rémunération totale de Jim ($USD 2.24M ) est inférieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 3.30M ).
Rémunération et revenus: La rémunération de Jim a augmenté alors que l'entreprise n'est pas rentable.
PDG
Jim Swift (62 yo)
1.6yrs
Titularisation
US$2,237,839
Compensation
Dr. James D. Swift, M.D., also known as Jim, is Director of Brave Care, Inc. since October 2021. He had been the Chief Operating Officer at Pediatrix Medical Group, Inc. since May 2022 until December 31, 2...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 1.6yrs | US$2.24m | 0.21% $ 2.0m | |
| Executive VP & CFO | 3.9yrs | US$1.78m | 0.21% $ 1.9m | |
| Executive VP & COO | 1.5yrs | US$1.88m | 0.17% $ 1.5m | |
| Executive VP | 1.8yrs | US$1.83m | 0.19% $ 1.7m | |
| Senior VP & Chief Accounting Officer | 8.3yrs | US$1.43m | pas de données | |
| Senior VP & Chief Information Officer | 2.6yrs | pas de données | pas de données | |
| Senior Vice President of Administration & Managed Care | no data | pas de données | pas de données | |
| Senior VP of Finance | no data | pas de données | pas de données | |
| Senior VP | 3yrs | pas de données | pas de données | |
| President of Regional Operations (Central) | no data | pas de données | pas de données | |
| President of Regional Operations (South-Central) | no data | pas de données | pas de données | |
| Senior Vice President of Operations | no data | pas de données | pas de données |
2.6yrs
Durée moyenne de l'emploi
62yo
Âge moyen
Gestion expérimentée: L'équipe de direction de MD est considérée comme expérimentée (ancienneté moyenne 2.6 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 1.4yrs | US$2.24m | 0.21% $ 2.0m | |
| Chair | 4.1yrs | US$554.45k | 0.20% $ 1.8m | |
| Lead Independent Director | 4.1yrs | US$295.00k | 0.081% $ 736.5k | |
| Independent Director | 4.1yrs | US$252.50k | 0.065% $ 589.1k | |
| Independent Director | 1.3yrs | US$201.00k | 0.035% $ 314.7k | |
| Independent Director | 4.1yrs | US$230.00k | 0.065% $ 589.0k | |
| Independent Director | 4.1yrs | US$245.00k | 0.043% $ 388.4k | |
| Board Observer | 4.1yrs | pas de données | pas de données | |
| Independent Director | 5.3yrs | US$242.50k | 0.069% $ 626.9k | |
| Independent Director | 2.3yrs | US$230.00k | 0.023% $ 209.6k |
4.1yrs
Durée moyenne de l'emploi
61yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de MD sont considérés comme expérimentés (ancienneté moyenne 4.1 ans).